Background: Tennis elbow (TE) is a common myotendinosis. It was first described by Runge in 1873; different modes of treatment are used in management of TE. Objectives: This study aimed to report the results of autologous blood injection (ABI) in the treatment of TE. Materials and Methods: A prospective case study was performed to evaluate the results of ABI in the management of TE. The level of pain based on Nirschl phase scale (NPS) and a visual analogue scale (VAS) was calculated before and 1, 3 and 6 months after injection; then satisfaction was assessed. Results: Twenty-nine patients with diagnosed TE were treated by ABI (24% males, 76 % female). The mean age of the patients was 44.1 ± 5.2 years. The level of pain on VAS decreased from 6.46 ± 2.08 to 0.54 ± 0.7 (P=0.001) and on NPS from 6.15 ± 1.48 to 0.54 ± 0.76 (P = 0.001) 6 months after treatment. At the end of the study, 84% of patients expressed a high level of satisfaction. Conclusions: Given the acceptable outcomes, autologous blood injection can be considered a good treatment option for TE when traditional treatment has fails.
Karimi Mobarakeh, M., Nemati, A., Fallahi, A., Safari, S. (2012). Autologous Blood Injection for Treatment of Tennis Elbow. Trauma Monthly, 17(4), 393-395. doi: 10.5812/traumamon.5095
MLA
Mahmood Karimi Mobarakeh; Ali Nemati; Amirhossein Fallahi; Saeid Safari. "Autologous Blood Injection for Treatment of Tennis Elbow". Trauma Monthly, 17, 4, 2012, 393-395. doi: 10.5812/traumamon.5095
HARVARD
Karimi Mobarakeh, M., Nemati, A., Fallahi, A., Safari, S. (2012). 'Autologous Blood Injection for Treatment of Tennis Elbow', Trauma Monthly, 17(4), pp. 393-395. doi: 10.5812/traumamon.5095
VANCOUVER
Karimi Mobarakeh, M., Nemati, A., Fallahi, A., Safari, S. Autologous Blood Injection for Treatment of Tennis Elbow. Trauma Monthly, 2012; 17(4): 393-395. doi: 10.5812/traumamon.5095
)